331949-29-2Relevant articles and documents
Synthesis of 5/7-, 5/8- And 5/9-bicyclic lactam templates as constraints for external β-turns
Duggan, Heather M. E.,Hitchcock, Peter B.,Young, Douglas W.
, p. 2287 - 2295 (2007/10/03)
The 5/7-, 5/8- and 5/9-bicyclic lactams 3, 17, 5 and 6 have been synthesised as single diastereoisomers by a route involving ring closing olefin metathesis. The X-ray crystal structure of the amino acid hydrochloride 17 has been carried out and compared t
A concise asymmetric route to the bridged bicyclic tropane alkaloid ferruginine using enyne ring-closing metathesis
Aggarwal, Varinder K.,Astle, Christopher J.,Rogers-Evans, Mark
, p. 1469 - 1471 (2007/10/03)
Enyne metathesis has been used to prepare bridged azabicycles and applied in a short asymmetric synthesis of the tropane ferruginine. A Grubbs first generation catalyst proved to be superior to the second generation catalyst in the enyne metathesis reaction.
Carbapenem biosynthesis: Confirmation of stereochemical assignments and the role of CarC in the ring stereoinversion process from L-Proline
Stapon, Anthony,Li, Rongfeng,Townsend, Craig A.
, p. 8486 - 8493 (2007/10/03)
(5R)-Carbapen-2-em-3-carboxylic acid is the simplest structurally among the naturally occurring carbapenem β-lactam antibiotics. It co-occurs with two saturated (3S,5S)- and (3S,5R)-carbapenam carboxylic acids. Confusion persists in the literature about t
Synthesis of benzyl (6S)-1,3-dichloro-4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6- carboxylic ester, a new conformationally constrained peptidomimetic derivative
Gloanec, Philippe,Hervé, Yolande,Brémand, Nathalie,Lecouvé, Jean-Pierre,Bréard, Fabienne,De Nanteuil, Guillaume
, p. 3499 - 3501 (2007/10/03)
We describe the synthesis of benzyl (6S)-1,3-dichloro-4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6- carboxylic ester, a new conformationally constrained peptidomimetic derivative. This compound is prepared in seven steps from (S)-pyroglutamic acid as starting material.
Bicyclic amino-pyrazinone compounds
-
, (2008/06/13)
A compound selected from those of formula (I): wherein: R1represents hydrogen, optionally substituted alkyl, cycloalkyl or heterocycloalkyl or a group of formula (G): wherein A1represents single, —CH2—, —CH2—CH2— or —N(CH3)— or oxygen or sulphur, and X1and X2, which may be identical or different, each represent carbon or nitrogen, R represents hydrogen or linear or branched (C1-C6)alkyl, ?represents a saturated ring having from 4 to 7 ring members, n represents integer wherein 1≦n≦6, Ar represents aryl or heteroaryl, its isomers, N-oxydes and pharmaceutically-acceptable acid or base addition salts thereof.
Improved synthesis of (2S,5S)-5-tert-butylproline
Halab, Liliane,Bélec, Laurent,Lubell, William D
, p. 6439 - 6446 (2007/10/03)
(2S,5S)-N-Boc-5-tert-butylproline (1) was synthesized by an improved procedure featuring the conversion of (2S)-1-tert-butyldimethylsiloxy-2-N-(PhF)amino-5-oxo-6,6-dimethylheptane (16) into its corresponding imino alcohol followed by directed hydride deli